首页|Ex vivo liver resection and auto-transplantation as an alternative for the treatment of liver malignancies:Progress and challenges
Ex vivo liver resection and auto-transplantation as an alternative for the treatment of liver malignancies:Progress and challenges
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
国家科技期刊平台
NETL
NSTL
万方数据
Hepatectomy is still the major curative treatment for patients with liver malignancies.However,it is still a big challenge to remove the tumors in the central posterior area,especially if their location involves the retrohepatic inferior vena cava and hepatic veins.Ex vivo liver resection and auto-transplantation(ELRA),a hybrid technique of the traditional liver resection and transplantation,has brought new hope to these patients and therefore becomes a valid alternative to liver transplantation.Due to its technical difficulty,ELRA is still concentrated in a few hepatobiliary centers that have experienced surgeons in both liver re-section and liver transplantation.The efficacy and safety of this technique has already been demonstrated in the treatment of benign liver diseases,especially in the advanced alveolar echinococcosis.Recently,the application of ELRA for liver malignances has gained more attention.However,standardization of clinical practice norms and international consensus are still lacking.The prognostic impact in these oncologic pa-tients also needs further evaluation.In this review,we summarized the principles and recent progresses on ELRA.
Ex vivo liver resectionLiver auto-transplantationOncologyLiver malignancies
Hepatobiliary Surgery and Liver Transplantation Centers,Department of General Surgery,Huashan Hospital & Cancer Metastasis Institute,Fudan University,Shanghai 200040,China
国家科技期刊平台
NSTL
万方数据
